Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Therapeutisches Forschungsprotokoll Dosis: 1000 mcg / 1 mg (2 Kapseln) Dauer: 6 8 Wochen Hufigkeit: 1 Kapsel zweimal tglich, morgens und abends Zyklusintervall: 4 Wochen Pause vor Wiederholung Ziel / Beschreibung: Hher dosiertes orales Regime, evaluiert in Modellen zur Reparatur von Sehnen, Bndern und Darmbarriere
The majority of this evidence comes from in vitro fibroblast cultures and animal work
However, like all research compounds, it still carries risksespecially when improperly dosed, reconstituted, or sourced from unverified suppliers
For hormonally-driven conditions like melasma, maintenance is key, as hormonal shifts can trigger new discoloration
